Quantitative Electroencephalography-Guided tDCS Intervention in Negative Emotion and Fear Extinction during Covid-19 Pandemic

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200062142

Enrollment

Unknown

Registered

2022-07-25

Start date

2022-09-01

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety and Depression disorders

Interventions

clinical group:tDCS

control group:qEEG

Eligibility

Sex/Gender

All

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Male or female between the age of 20 and 45 with a history of anxiety and depressive symptoms that cause significant distress or impairment in functioning, right-handed (except two left-handed patients), English proficient speakers, normal and corrected-to-normal vision, and no history of neurological disorders. All participants are proficient bilinguals (living and working in an English speaking country) and learned English as a second language (L2).

Exclusion criteria

Exclusion criteria: The exclusion criteria include the presence of substance use, general medical conditions, and symptoms that are better explained by bereavement.

Design outcomes

Primary

Measure	Time frame
neuromodulation effect - negative emotion;neuromodulation effect - fear;	—

Countries

Hong Kong, China

Contacts

Public ContactZhen Yuan

Faculty of Health Sciences; University of Macau

zhenyuan@umac.mo+86 853 88224989

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026